Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FDL22
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,275
Award facts
- Contract value 100% obligated
- $98,274.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for $98.3K on August 19, 2025. The order covers the supply of Keytruda (pembrolizumab) 100 mg/4 mL vials, an oncology therapeutic used in cancer treatment protocols. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, was issued without a set-aside designation, reflecting the vendor's competitive positioning in federal pharmaceutical procurement. The place of performance is located in Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its operations.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.9M through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. The vendor's established portfolio includes specialized pharmaceutical distribution encompassing prescription medications, biologics, and medical consumables. This award demonstrates the continued role of DMS Pharmaceutical Group as a critical supplier within the federal pharmaceutical supply chain, providing direct distribution of specialty pharmaceuticals to military healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FDL22?
SPE2DB25FDL22 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FDL22 worth?
The government has obligated $98,275 on SPE2DB25FDL22.
Is contract SPE2DB25FDL22 an order under another contract?
Yes. SPE2DB25FDL22 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL22 competed?
The extent of competition for SPE2DB25FDL22 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award